Oxylan Depot 20 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

oxylan depot 20 mg depottabletter

g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 20 mg

Oxylan Depot 40 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

oxylan depot 40 mg depottabletter

g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 40 mg

Oxylan Depot 80 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

oxylan depot 80 mg depottabletter

g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 80 mg

Oxylan Depot 5 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

oxylan depot 5 mg depottabletter

g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 5 mg

Celsunax Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

celsunax

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. hos voksne patienter, til at hjælpe med at differentiere sandsynligt, demens med lewy organer fra alzheimers sygdom.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Grasustek Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

grasustek

juta pharma gmbh - pegfilgrastim - neutropeni - immunostimulants, - reduktion i varigheden af neutropeni og forekomst af febril neutropeni hos voksne patienter behandlet med cytotoksisk kemoterapi for malignitet (med undtagelse af kronisk myeloid leukæmi og myelodysplastisk syndromer).

Depolan 30 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

depolan 30 mg depottabletter

g.l. pharma gmbh - morphinhydrochloridtrihydrat - depottabletter - 30 mg

Depolan 60 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

depolan 60 mg depottabletter

g.l. pharma gmbh - morphinhydrochloridtrihydrat - depottabletter - 60 mg

Depolan 10 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

depolan 10 mg depottabletter

g.l. pharma gmbh - morphinhydrochloridtrihydrat - depottabletter - 10 mg

Depolan 100 mg depottabletter Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

depolan 100 mg depottabletter

g.l. pharma gmbh - morphinhydrochloridtrihydrat - depottabletter - 100 mg